Pharmaceuticals company Johnson & Johnson has accelerated the first in-human clinical trial of its investigational SARS-CoV-2 vaccine. It will commence in the
Turkish President Recep Tayyip Erdogan announced further easing of the restrictions against the COVID-19 pandemic as Turkey has entered a normalization process.